RECURSION PHARMACEUTICALS, INC.

By person

22 insiders · 461 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Mubadala Investment Co PJSC entity

10% owner

$62.90M (28)

—

+$62.90M

21,726,844

$76.43M

+1,195%

Gibson Christopher

Director

—

$39.44M (226) scheduled

−$39.44M

9,381,826

$33.00M

+9.2%

Borgeson Blake

Director

—

$10.39M (72) scheduled

−$10.39M

6,158,287

$21.66M

−8.9%

Secora Michael

Chief Financial Officer

—

$6.40M (39) scheduled

−$6.40M

1,487,694

$5.23M

+285.5%

Virani Shafique

Chief Business Officer

—

$4.21M (25) scheduled

−$4.21M

136,748

$481.02K

+502.7%

Marriott Tina

President and COO

—

$1.89M (34) scheduled

−$1.89M

506,852

$1.78M

—

Lux Ventures IV, L.P. entity

Former 10% Owner

$1.80M (1)

—

+$1.80M

30,308,614

$106.61M

+75.2%

Burrell Terry-Ann

Director

—

$1.41M (5)

−$1.41M

71,254

$250.64K

−43.7%

Li Dean Y

Director

—

$1.11M (6)

−$1.11M

6,916,377

$24.33M

−5.9%

Khan Najat

CEO and President

—

$1.01M (5) scheduled

−$1.01M

2,072,890

$7.29M

—

Dar Zavain

Director

—

$181.27K (1) scheduled

−$181.27K

240,764

$846.91K

+277.5%

Taylor Ben R

Chief Financial Officer

—

$157.70K (3) scheduled

−$157.70K

1,071,462

$3.77M

+115.8%

Bumpus Namandje

Director

—

$28.13K (2) scheduled

−$28.13K

127,632

$448.96K

—

Bogue Zachary

Director

—

3,736,341

$13.14M

—

Data Collective IV, L.P.

10% owner

—

3,726,963

$13.11M

—

Hallett David

Chief Scientific Officer

—

1,043,837

$3.67M

+75.7%

Mauro David J

Chief Medical Officer

—

225,429

$792.97K

—

Michor Franziska

Director

—

215,477

$757.96K

—

HERSHBERG ROBERT

Director

—

162,156

$570.40K

—

Sun Elaine D

Director

—

135,981

$478.33K

—

Doyle Ramona

Chief Medical Officer

—

121,110

$426.02K

+8,626%

CHAVEZ R. MARTIN

Director

—

60,078

$211.33K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Gibson Christopher

30 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Gibson Christopher

29 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Gibson Christopher

28 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Gibson Christopher

27 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Gibson Christopher

26 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Gibson Christopher

23 Aug 2024

Chief Executive Officer

Exercised, kept

5,000

$2.48

$12.40K

Showing 250 of 461 transactions. The figures above use every one of them.

RECURSION PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out